Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T

Angela Dispenzieri, Morie A. Gertz, Amy Saenger, Shaji K. Kumar, Martha Q. Lacy, Francis K. Buadi, David Dingli, Nelson Leung, Steven Zeldenrust, Suzanne R. Hayman, Prashant Kapoor, Martha Grogan, Lisa Hwa, Stephen J. Russell, Ronald S. Go, S. Vincent Rajkumar, Robert A. Kyle, Allan Jaffe

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T'. Together they form a unique fingerprint.

Medicine & Life Sciences